Internal Medicine · Clermont, FL
NPI
1497981187
Since 2009
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
1920 Don Wickham Dr Ste 140
Clermont, FL, 34711
Phone (352) 227-3341
Groups this clinician bills Medicare through
Medicare paid, 2024
$301K
3,794 services
Medicare patients, 2024
315
Average age 74
Drug cost, 2024
$1.1M
11,267 prescriptions
Company payments, 2025
$579
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aasma Riaz was code 99214 (office e&m - established), 1,078 times for 301 patients. In total Aasma Riaz billed 3,794 services in 79 codes, and Medicare paid $301K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-10-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,078 | 301 | $87.85 | $95K |
| 99213 Office E&M - Established | Office | 276 | 154 | $64.89 | $18K |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 263 | 263 | $17.96 | $4,724 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 245 | 245 | $17.96 | $4,400 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 237 | 237 | $125.63 | $30K |
| 87428 Infectious Agent Detection by DNA/RNA | Office | 92 | 72 | $68.88 | $6,337 |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 79 | 76 | $24.64 | $1,946 |
| 93925 Duplex Scan - Extremity Arteries | Office | 74 | 72 | $168.65 | $12K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 73 | 70 | $133.41 | $9,739 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 71 | 17 | $0.72 | $50.96 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 51 | 43 | $212.78 | $11K |
| 99215 Office E&M - Established | Office | 48 | 42 | $134.66 | $6,463 |
| G0008 Administration of influenza virus vaccine | Office | 47 | 47 | $31.66 | $1,488 |
| 93000 Electrocardiogram | Office | 39 | 37 | $10.22 | $399 |
| 90656 Vaccine Product | Office | 38 | 38 | $21.90 | $832 |
By year: 2022 $209K for 3,176 services; 2023 $300K for 3,480 services; 2024 $301K for 3,794 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87428 Infectious Agent Detection by DNA/RNA | 92 | 72 | $68.88 | $6,337 |
| 87880 Immunoassay | 31 | 24 | $16.20 | $502 |
| 36415 Venipuncture Blood Collection | 26 | 24 | $5.88 | $153 |
| 87420 Immunoassay | 15 | 15 | $13.63 | $204 |
Medicare prescription drug claims, 2024
In 2024, the drug Aasma Riaz prescribed most often to Medicare patients was Atorvastatin Calcium, with 770 prescriptions and refills. In total Aasma Riaz wrote 11,267 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 770 | 2,282 | 260 | $6,230 |
| Amlodipine Besylate Generic | 452 | 1,318 | 143 | $2,411 |
| Rosuvastatin Calcium Generic | 434 | 1,297 | 164 | $5,133 |
| Levothyroxine Sodium Generic | 413 | 1,201 | 124 | $4,259 |
| Lisinopril Generic | 350 | 1,020 | 114 | $1,985 |
| Losartan Potassium Generic | 334 | 990 | 114 | $2,919 |
| Metformin Hcl Generic | 259 | 734 | 80 | $1,495 |
| Montelukast Sodium Generic | 230 | 677 | 85 | $2,306 |
| Omeprazole Generic | 212 | 629 | 72 | $2,914 |
| Famotidine Generic | 211 | 558 | 101 | $2,574 |
| Metoprolol Succinate Generic | 190 | 561 | 61 | $2,693 |
| Prednisone Generic | 181 | 209 | 123 | $512 |
| Duloxetine Hcl Generic | 160 | 426 | 63 | $7,851 |
| Metoprolol Tartrate Generic | 157 | 470 | 55 | $1,366 |
| Pantoprazole Sodium Generic | 143 | 410 | 57 | $2,310 |
Brand drugs: 1,354 claims; generic drugs: 9,813 claims; opioid claims: 84.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aasma Riaz $579 ($579 in general payments such as food, travel and fees) from 11 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $96.53.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 4 | $96.53 |
| Next Science LLC NXS.AX | 2 | $88.45 |
| Novo Nordisk Inc NVO | 4 | $86.01 |
| Abbvie Inc. ABBV | 3 | $67.2 |
| Amgen Inc. AMGN | 3 | $56.23 |
| GlaxoSmithKline, LLC. GSK | 2 | $54.38 |
| Lilly USA, LLC LLY | 2 | $43.13 |
| Exact Sciences Corporation EXAS | 1 | $32.25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $20.62 |
| Smith+Nephew, Inc. SNN | 1 | $17.48 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.